Detalles de la búsqueda
1.
Design, synthesis, and biological evaluation of a new series of pyrazole derivatives: Discovery of potent and selective JNK3 kinase inhibitors.
Bioorg Med Chem
; 69: 116894, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35764033
2.
Evaluation of imidazo[2,1-b]thiazole-based anticancer agents in one decade (2011-2020): Current status and future prospects.
Bioorg Med Chem
; 29: 115897, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33316752
3.
Design and synthesis of new quinoline derivatives as selective C-RAF kinase inhibitors with potent anticancer activity.
Eur J Med Chem
; 238: 114434, 2022 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35551038
4.
Synthesis, biological evaluation, and docking studies of novel pyrrolo[2,3-b]pyridine derivatives as both ectonucleotide pyrophosphatase/phosphodiesterase inhibitors and antiproliferative agents.
Eur J Med Chem
; 217: 113339, 2021 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33744686
5.
Discovery of first-in-class imidazothiazole-based potent and selective ErbB4 (HER4) kinase inhibitors.
Eur J Med Chem
; 224: 113674, 2021 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34237622
6.
Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells.
Eur J Med Chem
; 210: 113081, 2021 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33310290
Resultados
1 -
6
de 6
1
Próxima >
>>